Tenon Medical Reports Q2 2026 Financial Results; Hosts Conference Call

What Happened
Tenon Medical, Inc. (TNON) announced its financial results for the quarter ended June 30, 2026 via a press release dated August 13, 2026, and filed an 8‑K (Item 2.02) to disclose the release. The company held a conference call the same day, August 13, 2026, at 4:30 p.m. ET (1:30 p.m. PT) to discuss the results, provide a corporate update, and answer questions from its covering analyst. An audio replay is available through August 27, 2026, on the company’s investor relations site or by telephone (access code 13761819). The press release is furnished as Exhibit 99.1 to the 8‑K.

Key Details

• Reporting period: quarter ended June 30, 2026.
• Press release date: August 13, 2026; furnished as Exhibit 99.1 to the Form 8‑K.
• Conference call: August 13, 2026 at 4:30 p.m. ET (1:30 p.m. PT).
• Replay availability: through August 27, 2026 at http://ir.tenonmed.com/ or by phone (US: 1-844-512-2921; Intl: 1-412-317-6671), access code 13761819.

Why It Matters
This 8‑K alerts investors that Tenon has released its quarterly earnings and provided management commentary via a live call — key sources for evaluating recent performance, revenue and profitability trends, and any near‑term operational updates. Retail investors should review the press release and replay to see the actual financial figures and management’s discussion, which will be necessary to assess impacts on the company’s outlook and investment thesis. Note: the press release is furnished (not “filed”) in the Form 8‑K, per the company’s statement.